Patents by Inventor Wai-Lung NG

Wai-Lung NG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230357168
    Abstract: Carbobicyclic nucleoside compounds useful for the treatment of coronavirus disease 2019 (COVID-19), RSV and other viral infections are provided. The carbobicyclic nucleoside compound may be a compound as set forth herein. Pharmaceutical formulations useful for treatment of COVID-19 and RSV are also described.
    Type: Application
    Filed: April 14, 2023
    Publication date: November 9, 2023
    Inventors: Wai-Lung NG, Mao-Yun LYU, Stephan SCHEEFF
  • Patent number: 10759729
    Abstract: The present invention provides a class of novel aryl pseudo-C-glycoside compounds that are effective for treating diabetes. Also provided are methods for making such compounds and methods for treating diabetes by administering such compounds to patients who have been diagnosed with diabetes or are at risk of developing diabetes.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: September 1, 2020
    Assignee: The Chinese University of Hong Kong
    Inventors: Tony Kung Ming Shing, Wai-Lung Ng, Ho Chuen Li, Kit-Man Lau, Clara Bik San Lau
  • Publication number: 20180127343
    Abstract: The present invention provides a class of novel aryl pseudo-C-glycoside compounds that are effective for treating diabetes. Also provided are methods for making such compounds and methods for treating diabetes by administering such compounds to patients who have been diagnosed with diabetes or are at risk of developing diabetes.
    Type: Application
    Filed: November 7, 2016
    Publication date: May 10, 2018
    Inventors: Tony Kung Ming Shing, Wai-Lung NG, Ho Chuen LI, Kit-Man LAU, Clara Bik San LAU